Skip to main content
Subscribe
Sign in
Menu
Membership
Events
Knowledge Center
About
Register
Search
Sign In
Sign In
Register
Subscribe
Stephen Taub
Latest Articles
For Members Only
Glenview Extends Losses in September
Stephen Taub
October 5, 2022
For Members Only
Hedge Funds Go Bottom Fishing in Biopharma
Stephen Taub
October 4, 2022
For Members Only
Greenlight Sidesteps September Swoon
Stephen Taub
October 3, 2022
For Members Only
Storm Clouds on the Horizon
Stephen Taub
September 30, 2022
For Members Only
Cadian Launches a New Fund
Stephen Taub
September 29, 2022
For Members Only
VC Investing Continues to Decline
Stephen Taub
September 28, 2022
For Members Only
Aurelius Capital’s Drawdown Funds Soar in 2022
Stephen Taub
September 27, 2022
For Members Only
Jana’s Latest Target
Stephen Taub
September 26, 2022
For Members Only
Oyo Valuation Cut Rocks Investors
Stephen Taub
September 23, 2022
For Members Only
Woodson Remains Committed to Peloton
Stephen Taub
September 22, 2022
For Members Only
Averill Suffers a Setback
Stephen Taub
September 21, 2022
For Members Only
Biopharma’s Healthy Private Market
Stephen Taub
September 20, 2022
For Members Only
D. E. Shaw’s Latest New Fund
Stephen Taub
September 19, 2022
For Members Only
Whale Rock Extends Losses
Stephen Taub
September 16, 2022
For Members Only
Life Sciences Funds Show Some Signs of Health
Stephen Taub
September 15, 2022
For Members Only
Tiger-Related Funds Settle Down in August
Stephen Taub
September 14, 2022
For Members Only
Light Street’s Already Difficult 2022 Gets More Complicated
Stephen Taub
September 13, 2022
For Members Only
A Tough Year for the $2 Billion Man
Stephen Taub
September 12, 2022
More Articles